Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Dry Eye > Study investigates intereye agreement in dry eye disease signs
  • Dry Eye

Study investigates intereye agreement in dry eye disease signs

Kelsey Moroz

Although there is generally moderate-to-good agreement between the eyes in dry eye disease (DED) signs, a significant proportion of patients exhibit clinically important differences between their eyes, according to a study.

The research, conducted as part of the Dry Eye Assessment and Management study, evaluated various diagnostic metrics at baseline, 3, 6, and 12 months.

The study employed intraclass correlation coefficients, weighted kappa statistics, and percentage of participants with absolute intereye differences (AID) exceeding clinically significant thresholds to assess agreement. Results indicated moderate-to-good intereye agreement across different DED signs. Specifically, intraclass correlation coefficients ranged from 0.45 for tear osmolarity to 0.81 for corneal staining and the Schirmer test. Weighted kappa values ranged from 0.58 for plugging to 0.69 for lid secretion.

However, the study also found a notable percentage of participants exhibiting clinically significant intereye differences. AID percentages ranged from 15% to 47% across different metrics, with tear osmolarity showing the highest discrepancy at 44% to 47%. In addition, the eye with worse DED signs varied from 36% of participants for TBUT to 80% for osmolarity.

The researchers concluded that this variability underscores the importance of evaluating both eyes in future DED clinical trials.

Reference
Zhong A, Augello P, Asbell P, et al; DREAM Study Research Group. Intereye Agreement in Dry-Eye Signs in the DREAM Study: Implications for Future Dry-Eye Trials. Cornea. 2024;doi: 10.1097/ICO.0000000000003605. Epub ahead of print. PMID: 39079754.

Share

Related Content

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

  • Conference Roundup

New screening device for keratoconus may help identify patients earlier

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon